CID 135466554

Pyridazinone derivative, 8b

Structural Information

Molecular Formula
C20H20N4O4S2
SMILES
CC(C)CCN1C(=O)C(=C(C(=N1)C2=CC=CS2)O)C3=NS(=O)(=O)C4=CC=CC=C4N3
InChI
InChI=1S/C20H20N4O4S2/c1-12(2)9-10-24-20(26)16(18(25)17(22-24)14-7-5-11-29-14)19-21-13-6-3-4-8-15(13)30(27,28)23-19/h3-8,11-12,25H,9-10H2,1-2H3,(H,21,23)
InChIKey
SVLHDHVYVKADRI-UHFFFAOYSA-N
Compound name
4-(1,1-dioxo-4H-1lambda6,2,4-benzothiadiazin-3-yl)-5-hydroxy-2-(3-methylbutyl)-6-thiophen-2-ylpyridazin-3-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

3
Patents

444.0926 Da
Monoisotopic Mass

3.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 445.09988 198.1
[M+Na]+ 467.08182 209.1
[M-H]- 443.08532 201.8
[M+NH4]+ 462.12642 206.5
[M+K]+ 483.05576 200.8
[M+H-H2O]+ 427.08986 190.9
[M+HCOO]- 489.09080 203.2
[M+CH3COO]- 503.10645 206.0
[M+Na-2H]- 465.06727 197.7
[M]+ 444.09205 202.7
[M]- 444.09315 202.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe